Back to LYEL

UBS Group AG → LYEL

UBS Group AG LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
13
Latest value
$824K
Q3 2026
Peak value
$824K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$4K
Q3 2025$341K
Q3 2025$65
Q4 2025$8K
Q4 2025$396K
Q4 2025$3K
Q1 2026$5K
Q1 2026$564K
Q1 2026$70K
Q2 2026$4K
Q2 2026$357K
Q2 2026$5K
Q3 2026$824K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$824K84.1K——
Q2 2026$5K337——
Q2 2026$357K25.4K——
Q2 2026$4K250——
Q1 2026$70K3.5K——
Q1 2026$564K28.1K——
Q1 2026$5K250——
Q4 2025$3K100——
Q4 2025$396K12.9K——
Q4 2025$8K250——
Q3 2025$654——
Q3 2025$341K21.0K——
Q3 2025$4K250——

Other funds holding LYEL

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B